BIOTA PHARMACEUTIALS INC's ticker is BOTA and the CUSIP is 090694100. A total of 46 filers reported holding BIOTA PHARMACEUTIALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $121,000 | -28.0% | 80,576 | -6.7% | 0.00% | – |
| Q4 2015 | $168,000 | +3.7% | 86,390 | +5.8% | 0.00% | – |
| Q3 2015 | $162,000 | -6.4% | 81,619 | -2.6% | 0.00% | – |
| Q2 2015 | $173,000 | -12.6% | 83,779 | -2.5% | 0.00% | – |
| Q1 2015 | $198,000 | -4.3% | 85,901 | -7.1% | 0.00% | – |
| Q4 2014 | $207,000 | -2.4% | 92,474 | +7.7% | 0.00% | – |
| Q3 2014 | $212,000 | -19.4% | 85,868 | -6.8% | 0.00% | – |
| Q2 2014 | $263,000 | -52.9% | 92,107 | +0.8% | 0.00% | – |
| Q1 2014 | $558,000 | +102.9% | 91,407 | +39.3% | 0.00% | – |
| Q4 2013 | $275,000 | +4.6% | 65,620 | +4.4% | 0.00% | – |
| Q3 2013 | $263,000 | – | 62,870 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 729,781 | $2,080,000 | 1.97% |
| Healthcare Value Capital, LLC | 145,507 | $415,000 | 0.35% |
| Broadfin Capital, LLC | 2,244,266 | $6,396,000 | 0.32% |
| TOWERVIEW LLC | 225,000 | $641,000,000 | 0.31% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 360,668 | $1,028,000 | 0.22% |
| Dominick & Dominick LLC | 146,016 | $416,000 | 0.20% |
| BVF INC/IL | 435,900 | $1,242,000 | 0.20% |
| Perceptive Advisors | 253,400 | $722,000 | 0.07% |
| BAILARD, INC. | 115,000 | $328,000 | 0.05% |
| KNOTT DAVID M | 88,100 | $251,085,000 | 0.04% |